(Q33194984)

23 July 2017

1 reference

title

Evolving revascularization approaches for myocardial ischemia (English)

1 reference

23 July 2017

1 reference

1 reference

5

1 reference

23 July 2017

Michael Simons

4

0 references

author name string

Neal S Kleiman

1

1 reference

23 July 2017

Nirav C Patel

2

1 reference

23 July 2017

Keith B Allen

3

1 reference

23 July 2017

Elaine Griffin

6

1 reference

23 July 2017

Victor J Dzau

7

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

American Journal of Cardiology

23 July 2017

published in

1 reference

23 July 2017

volume

92

1 reference

23 July 2017

issue

9B

1 reference

23 July 2017

page(s)

9N-17N

1 reference

Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Intracoronary stents: a review of the experience with five different devices in clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Intracoronary stents: will they fulfill their promise as an adjunct to angioplasty?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Angiographic follow-up after placement of a self-expanding coronary-artery stent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Pathology of in-stent restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Initial experience with paclitaxel-coated stents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Minimally invasive direct coronary artery bypass grafting: two-year clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

7 January 2021

Minimally invasive CABG.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

The revival of surgical treatment for isolated proximal high grade LAD lesions by minimally invasive coronary artery bypass grafting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Primary stenting versus MIDCAB: preliminary report-comparision of two methods of revascularization in single left anterior descending coronary artery stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

The effect off-pump coronary artery bypass surgery on in-hospital mortality and morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Endoscopic saphenous vein harvesting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Routine minimal invasive vein harvesting reduces postoperative morbidity in cardiac bypass procedures. Clinical report of 1400 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Endoscopic radial artery harvesting: results of first 300 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Endoscopic versus traditional saphenous vein harvesting: a prospective, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Endoscopic coronary artery bypass grafting with the aid of robotic assisted instruments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

The St Jude Medical symmetry aortic connector system for proximal vein graft anastomoses in coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Assessment of transmyocardial perfusion in alligator hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Transmyocardial laser treatment denervates canine myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Cardiac sympathetic denervation after transmyocardial laser revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Induction of angiogenesis after TMR: a comparison of holmium: YAG, CO2, and excimer lasers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Catheter-based transendocardial gene delivery for therapeutic myocardial angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Cardiovascular gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Therapeutic angiogenesis for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Del1 mediates VSMC adhesion, migration, and proliferation through interaction with integrin alpha(v)beta(3).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Novel molecular therapeutic approach to cardiovascular disease based on hepatocyte growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Platelet-derived growth factor-AA-mediated functional angiogenesis in the rat epigastric island flap after genetic modification of fibroblasts is ischemia dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

VEGF gene delivery for treatment of ischemic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Clinical and physiological effects of an acute alpha-1 adrenergic agonist and a beta-1 adrenergic antagonist in chronic orthostatic intolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

The role of fibroblast growth factors in vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900963-9

10.1016/S0002-9149(03)00963-9

7 January 2021

Identifiers

DOI

1 reference

23 July 2017

1 reference